EMVision Medical Devices Ltd. announced that as part of its ongoing succession planning process, Scott Kirkland has been appointed Chief Executive Officer (CEO) and Managing Director from 1 July 2023. Mr. Kirkland will succeed Dr Ron Weinberger, who has advised the Board of his intention to retire from his executive responsibilities, having served over five years in the role. Ron will revert to a non-executive director position and will also act as a consultant to the EMVision management team for an initial term until July 2024 to play an important role supporting clinical and product development, commercial partnering and the regulatory approvals process.

Scott Kirkland co-founded EMVision in 2017 and has been an Executive Director of the Company since its establishment. He has played an instrumental role in the development and commercial application of EMVision's revolutionary products, establishing the foundational team, leading corporate development, building clinical partnerships, including the Australian Stroke Alliance partnership, and securing awards of close to $20M in Federal and State non-dilutive grants since inception. Prior to EMVision, Scott held several senior sales positions, including Head of Client Sales at Quantcast, a US-based venture backed technology company.